drugset / Trial / NCT02065375
RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
This study assesses the efficacy and safety of two concentrations of RTA 408 Ophthalmic Suspension in the treatment of patients who have inflammation and pain following ocular surgery.
Timeline
- Start
- 2014-02-28
- Primary completion
- 2014-09-30
- Completion
- 2014-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omaveloxolone | Small molecule | 0.5 % | Other |
| Subject | Omaveloxolone | Small molecule | 1 % | Other |